Compounds > phenformin
Page last updated: 2024-08-18

phenformin and Cancer of Skin

phenformin has been researched along with Cancer of Skin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Dotto, GP; Huang, M; Kim, SH; Liu, C; Pérez-Lorenzo, R; Wu, X; Zheng, B; Zhou, Q1
Kim, SH; Li, M; Pasca di Magliano, M; Swanson, KD; Trousil, S; Zhang, Y; Zheng, B1
Beaulieu, D; Nijhawan, RI1
Lilla, C; Livingstone, E; Roesch, A; Schadendorf, D; Swann, S1
Albini, A; Argenziano, G; Ciarrocchi, A; Dallaglio, K; Dominici, M; Grisendi, G; Longo, C; Petrachi, T; Romagnani, A1
Anichini, A; Bersani, I; Cleris, L; Formelli, F; Hardie, GD; Molla, A; Mustard, KJ; Petti, C; Sensi, M; Vegetti, C1

Other Studies

6 other study(ies) available for phenformin and Cancer of Skin

ArticleYear
Phenformin Promotes Keratinocyte Differentiation via the Calcineurin/NFAT Pathway.
    The Journal of investigative dermatology, 2021, Volume: 141, Issue:1

    Topics: Animals; Calcineurin; Cell Differentiation; Humans; Hypoglycemic Agents; Keratinocytes; Melanoma; Mice; Neoplasms, Experimental; Nitrofurans; Phenformin; Signal Transduction; Skin; Skin Neoplasms

2021
Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma.
    The Journal of investigative dermatology, 2017, Volume: 137, Issue:8

    Topics: Animals; Cell Line, Tumor; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Hypoglycemic Agents; Immunohistochemistry; Immunotherapy; Melanoma; Mice; Myeloid-Derived Suppressor Cells; Neoplasms, Experimental; Phenformin; Programmed Cell Death 1 Receptor; Real-Time Polymerase Chain Reaction; RNA, Neoplasm; Skin Neoplasms; Tumor Cells, Cultured

2017
Cells to Surgery Quiz: February 2018.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:2

    Topics: Humans; Keratinocytes; Melanoma; Myeloid-Derived Suppressor Cells; Nitric Oxide Synthase Type II; Phenformin; Skin; Skin Neoplasms; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2018
Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma.
    Experimental dermatology, 2015, Volume: 24, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hydrazines; Imidazoles; Indoles; Melanoma; Metformin; Mitochondria; Oxidative Phosphorylation; Oximes; Phenformin; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib

2015
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Aldehyde Dehydrogenase; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Metformin; Microphthalmia-Associated Transcription Factor; Neoplasm Invasiveness; Neoplastic Stem Cells; Phenformin; Phenotype; Skin Neoplasms; Spheroids, Cellular; Time Factors; Transfection

2017
AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
    Melanoma research, 2012, Volume: 22, Issue:5

    Topics: Amino Acid Sequence; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Enzyme Activators; Female; HEK293 Cells; Humans; Immunohistochemistry; Melanoma; Mice; Mice, Nude; Molecular Sequence Data; Phenformin; Phosphorylation; Ribonucleotides; Signal Transduction; Skin Neoplasms

2012